Clinical Trials Logo

Malignant Neoplasm of Stomach clinical trials

View clinical trials related to Malignant Neoplasm of Stomach.

Filter by:

NCT ID: NCT01443065 Completed - Clinical trials for Malignant Neoplasm of Stomach

MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal Adenocarcinoma

MEGA
Start date: January 2011
Phase: Phase 2
Study type: Interventional

This multicentre, open-label, randomized phase II trial is ongoing in 30 centres in France. Main eligibility criteria include: histologically proven adenocarcinoma of the stomach, esophagus or gastroesophageal junction; locally advanced or metastatic disease; measurable disease (RECIST 1.1); no known HER2 overexpression; no prior palliative chemotherapy.

NCT ID: NCT01187212 Completed - Clinical trials for Effects of Chemotherapy

Sorafenib Trial in Advanced and/or Recurrent Gastric Adenocarcinoma: Treatment Evaluation: STARGATE

Start date: August 2010
Phase: Phase 2
Study type: Interventional

This study investigates the efficacy and safety profiles of sorafenib in combination of capecitabine and cisplatin, one of standard chemotherapy regimens in patients with advanced gastric cancer.